Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Pan-Asian Adapted ESMO Clinical Practice Guidelines – Management of Patients with Locally-Advanced Unresectable NSCLC

Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients with Locally-Advanced Unresectable Non-Small-Cell Lung Cancer: A KSMO-ESMO Initiative Endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Published in 2020 – Ann Oncol (2020) 31:(2) 191–201.
Authors: K. Park; J. Vansteenkiste; K.H. Lee; G. Pentheroudakis; C. Zhou; K. Prabhash; T. Seto; P.J. Voon; D.S.W. Tan; J.C.H. Yang; J. Wang; K. Govind Babu; Y. Nakayama; A. Alip; K.L.M. Chua; J.C.H. Cheng; S. Senan; Y.C. Ahn; T.Y. Kim; H.K. Ahn; S. Peters; T. Yoshino; J.Y. Douillard

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.